Heart Disease Breakthrough: Protein Defects Link Cardiomyopathy to Alzheimer's

Researchers at the Medical University of South Carolina have uncovered key defects in the protein repair system linked to idiopathic dilated cardiomyopathy (IDCM). The study reveals that this condition, which weakens the heart’s pumping ability, shares striking similarities with neurodegenerative diseases like Alzheimer’s. Both involve the buildup of misfolded proteins, pointing to a shared underlying problem in how cells manage damaged proteins. IDCM is marked by an enlarged and weakened left ventricle, reducing the heart’s efficiency in circulating blood. The research team found that the protein repair system—responsible for maintaining proteostasis—fails in IDCM patients. This failure leads to the accumulation of harmful proteins and, ultimately, the death of cardiac cells.

The study examined three core components of the protein repair system: molecular chaperones, the ubiquitin-proteasome system, and autophagy-lysosomal pathways. All three were significantly impaired in IDCM. Additionally, the team observed clusters of misfolded protein plaques in the heart tissue of affected patients, mirroring those found in Alzheimer’s disease. Post-translational modifications (PTMs), which regulate protein function and stability, were also disrupted. These irregularities further destabilise the repair system, pushing cells toward programmed death. Dr. del Monte’s team suggests that a full map of these PTMs could pave the way for targeted IDCM therapies. Co-first author Camilla Bacchin is working to identify early biomarkers by analysing molecular signatures in cardiac tissue and blood. These markers could help detect IDCM progression sooner, transforming how patients are monitored and treated. The lab also proposes using cardiac imaging as a preclinical tool to assess neurodegenerative risk, framing the heart as a diagnostic window into brain health.

The findings position IDCM as a protein misfolding disorder, much like Alzheimer’s, with shared mechanisms of disease progression. By pinpointing defects in the protein repair system and developing early biomarkers, the research aims to improve diagnosis and treatment strategies. This could lead to better management of IDCM and potentially reduce its impact on patients’ lives.